NCT04855448

Evaluation of the Learning Curve in Low Anterior Resection for Rectal Resection With the Two Surgical Robots

Completed NA Last updated 22 April 2021

What this trial tests

NA trial testing Micro Hand S robot and da Vinci robot in Rectal Cancer in 112 participants. Completed in 31 October 2019.

Timeline

1 May 2017

Primary endpoint
31 August 2018

31 October 2019

Quick facts

Lead sponsor	The Third Xiangya Hospital of Central South University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	112
Start date	1 May 2017
Primary completion	31 August 2018
Estimated completion	31 October 2019
Sites	1 location across China

Drugs / interventions tested

• Micro Hand S robot and da Vinci robot
• da Vinci robot

Conditions studied

• Rectal Cancer — all drugs for Rectal Cancer →

Sponsor

The Third Xiangya Hospital of Central South University

Who can join

Adults 18 to 80, any sex, with Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. This new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University. The Micro Hand S robot is safe and feasible in the preliminary study. However, the learning curve in low anterior resection for rectal resection with the Micro Hand S robot are unclear and whether the two surgical robots (Micro Hand S and da Vinci) shared a similar learning curve and the two robot can be trained simultaneously. Therefore, the investigators conduct this retrospective study to focus on this concern.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.